Tag: Latent Labs

Latent Labs has launched Latent-Y, a new autonomous artificial intelligence agent designed to carry out therapeutic antibody design campaigns from a text prompt, research plan, or scientific paper, marking an ambitious step deeper into automated drug discovery. The London- and San Francisco-based company said the system can move from a research goal to lab-ready antibody…